companydata.dkcompanydata.dk

MR BIOINVEST ApS: Financial statements 2023

CVR: 25942817

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

MR BIOINVEST ApS (CVR 25942817) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -30,675 and a net result of DKK 1,861,816 compared with DKK -2,554,036 the year before. Equity in the 2023 report amounted to DKK 25,045,091. The solvency ratio was 99.6%.

Gross Profit
DKK -30,675
Profit/Loss
DKK 1,861,816
Equity
DKK 25,045,091
Total Assets
DKK 25,142,692
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--31K1.9M25M0
2022--28K-2.6M23.2M0
2021--34K2.7M25.7M0
2020--83K-102K23M0
2019--33K2.9M23.1M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

MR BIOINVEST ApS: The 2022 annual report is outMar 30, 2023

MR BIOINVEST ApS has published its annual report for 2022. Gross profit came to DKK -27,500, and the net result was DKK -2,554,036.

About MR BIOINVEST ApS

MR BIOINVEST ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2001. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Mads Aage Laustsen. The company is owned by Mads Aage Laustsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,875 and a net result of DKK 1,503,262 compared with DKK 1,669,196 the year before. Equity in the 2025 report amounted to DKK 28,217,549.

Source: annual report 2025, Danish Business Authority